Pharmacotherapy in pregnant women
DOI: 10.32364/2618-8430-2021-4-2-115-118
E.A. Sandakova1, I.G. Zhukovskaya2, M.V. Semenova2, A.F. Vaganova3, A.V. Kuznetsova1, T.E. Kazymova1, O.A. Belousova2, L.P. Makarova2
1Academician E.A. Vagner Perm State Medical University, Perm, Russian Federation
2Izhevsk State Medical Academy, Izhevsk, Russian Federation
3F.Kh. Gral City Clinical Hospital No. 2, Perm, Russian Federation
Aim: to analyze the prescription of medications in pregnant women based on outpatient charts of women’s clinics.
Patients and Methods: retrospective cohort study was conducted in three women’s clinics of Perm and two women’s clinics of Izhevsk. Data on the prescription of medications in 361 pregnant and postpartum women during pregnancy (2017–2018) were obtained by copying individual medical charts. Additionally, we compared our findings with the results of the Russian Pharmacoepidemiologic Study (2007).
Results: pharmacotherapy was prescribed in 100% of women. On average, 12.6 medications were prescribed during gestation. Most medications were prescribed in the second trimester (on average, 5.5 medications). In the first and third trimesters, 2.4 and 4.7 medications were prescribed, respectively. The most prescribed drugs were vitamins and minerals (70.4%), feminine hygiene products (37.1%), progestogens (33.1%), herbal urinary antiseptics (29.8%), and systemic antibiotics (14.2%). Pharmacotherapy defects included medications inconsistent with diagnosis (48.6%), a combination of several drugs with similar pharmacological effects (16.5%), and polypharmacy defined as the use of five or more medications (25.8%). A two-fold reduction in drug aggression as well as an increase in the dotation of vitamin-mineral complexes compared to 2007 were reported.
Conclusions: our findings illustrate positive trends for treating pregnant women in the last 9–10 years and increased safety of treatment (the lack of drugs with potential teratogenic or embryotoxic effects) but also indicate the need in the permanent audit and adjustment of prescriptions based on clinical guidelines. Pre-pregnancy preparation is a perspective way to reduce the intensity of drug therapy during pregnancy. As a result, drug burden shifts to a pre-gestational period. Pre-pregnancy preparation provides favorable conditions for developing an embryo and fetus.
Keywords: pharmacotherapy, pregnancy, polypharmacy, micronutrients, vaginal hygiene, progestogens, urinary antiseptics.
For citation: Sandakova E.A., Zhukovskaya I.G., Semenova M.V. et al. Pharmacotherapy in pregnant women. Russian Journal of Woman and Child Health. 2021;4(2):115–118. DOI: 10.32364/2618-8430-2021-4-2-115-118.
About the authors:
Elena A. Sandakova — Doct. of Sci. (Med.), Professor, Head of the Department of Obstetrics & Gynecology No. 2, Academician E.A. Vagner Perm State Medical University; 26, Petropavlovskaya str., Perm, 614990, Russian Federation.
Inna G. Zhukovskaya — Doct. of Sci. (Med.), associate professor of the Department of Obstetrics & Gynecology, Izhevsk State Medical Academy; 281, Kommunarov str., Izhevsk, 426034, Russian Federation; ORCID iD 0000-0002-7943-1115.
Margarita V. Semenova — Cand. of Sci. (Med.), Associate Professor, Head of the Department of Obstetrics & Gynecology, Izhevsk State Medical Academy; 281, Kommunarov str., Izhevsk, 426034, Russian Federation.
Anna F. Vaganova — obstetrician & gynecologist, F. Kh. Gral City Clinical Hospital No. 2; 230, Permskaya str., Perm, 614068, Russian Federation.
Anna V. Kuznetsova — postgraduate student of the Department of Obstetrics & Gynecology No. 2, Academician E.A. Vagner Perm State Medical University; 26, Petropavlovskaya str., Perm, 614990, Russian Federation.
Turana Elchu k. Kazymova — postgraduate student of the Department of Obstetrics & Gynecology No. 2, Academician E.A. Vagner Perm State Medical University; 26, Petropavlovskaya str., Perm, 614990, Russian Federation.
Olga A. Belousova — student of the 6th course of the Medical Faculty, Izhevsk State Medical Academy; 281, Kommunarov str., Izhevsk, 426034, Russian Federation.
Linda P. Makarova — student of the 6th course of the Medical Faculty, Izhevsk State Medical Academy; 281, Kommunarov str., Izhevsk, 426034, Russian Federation.
Contact information: Inna G. Zhukovskaya, e-mail: zhoukovskaya@mail.ru. Financial Disclosure: no authors have a financial or property interest in any material or method mentioned. There is no conflict of interests. Received 09.11.2020, revised 02.12.2020, accepted 25.12.2020.
2. Sokova E.A., Bunyatyan N.D., Mazerkina I.A. et al. Clinical studies of medicinal drugs in pregnant women: expected benefit-possible risk ratio? Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. 2015;(4):26–31 (in Russ.).
3. Sokova E.A. Safety monitoring of licensed medicinal drugs in pregnant women: pharmagenetic aspects. Safety and Risk of Pharmacotherapy. 2015;(3):30–35 (in Russ.).
4. Apresyan S.V. Pregnancy and partum in extragenital diseases. Radzinsky V.E., ed. M.: GEOTAR-Media; 2015 (in Russ.).
5. Zhukovskaya I.G., Sandakova E.A., Semenova M.V. Assessment of periconceptional supplementation of women with chronic inflammatory genital diseases based on in-depth study of wedded couple’s health. Treatment and Prevention. 2017;22(2):36–41 (in Russ.).
6. Radzinsky V.E., Pustotina O.A., Verizhnikova E.V. et al. Periconceptional care: clinical protocol. M.: StatusPraesens, 2016 (in Russ.).
7. Radzinsky V.E., Solovyev A.V., Ipastov I.D. Conception of minimal intervention. Rationalizing of the approach to medical drug prescription to the pregnant women. M.: StatusPraesens, 2018 (in Russ.).
8. Strizhenok E.A. Use of medicinal drugs in pregnancy: the results of multicenter pharmacological epidemiological study. Clinical Microbiology and Antimicrobial Chemotherapy. 2007;9(2):162–167 (in Russ.).
9. Archegova E.G., Bolieva L.Z., Tsogoev A.S. Assessment of medicinal drugs use in pregnant women in the Republic of North Ossetia-Alania: pharmacological epidemiological study. Journal of New Medical Technologies. 2017;(1):141–145 (in Russ.).
10. Eliseeva E.V., Pheoktistova Y.V., Poddubhy E.A. et al. Pharmacoepidemiology and pharmacovigilance: experience of regional clinical pharmacology service. Gynecology. 2013;15(4):52–55 (in Russ.).
11. Radzinsky V.E., ed. Pharmaceutical benefits of clinical protocols, Obstetrics and Gynecology. M.: GEOTAR-Media; 2019 (in Russ.).
12. Radzinsky V.E., Totchiev V.E., Panov A.E. Pharmacotherapy of pregnant women: simple rules of the present. Pharmateka. 2013;(3):77–79 (in Russ.).
13. Artymuk N.V. Alphabet truths. StatusPraesens. Gynecology, Obstetrics, Sterile marriage. 2016;4(33):17–21 (in Russ.).
14. Radzinsky V.E. Obstetrics aggression. M.: StatusPraesens; 2011 (in Russ.).
This work is licensed under a Creative Commons «Attribution» 4.0 License.
